false
--12-31
0001947861
0001947861
2025-12-04
2025-12-04
0001947861
NMHI:CommonStockParValue0.0001PerShareMember
2025-12-04
2025-12-04
0001947861
NMHI:WarrantsToPurchaseCommonStockAtExercisePriceOf11.50PerShareMember
2025-12-04
2025-12-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 4, 2025
NATURE'S MIRACLE HOLDING INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-41977 |
|
88-3986430 |
(State or other jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
3281 E. Guasti Road, Suite 175
Ontario, CA 91761 |
|
91761 |
| (Address of registrant’s principal executive office) |
|
(Zip code) |
(909) 218-4601
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act: None
Securities registered pursuant to Section
12(g) of the Act:
| Title for each class |
|
Trading Symbol(s) |
| Common Stock, par value $0.0001 per share |
|
NMHI |
| Warrants to purchase Common Stock, at an exercise price of $11.50 per share |
|
NMHIW |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.03. Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year.
On December 4, 2025,
Nature’s Miracle Holding Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate
of Incorporation with the Secretary of State of the State of Delaware to increase its authorized common stock, par value $0.0001 per share
(“Common Stock”), from 100,000,000 shares to 1,000,000,000 shares. The amendment was approved by the shareholders of the Company
owning a majority of the voting power of the Company’s outstanding Common Stock and preferred stock by written consent in lieu of
a special meeting upon the recommendation of the Board of Directors.
The Company previously mailed
a definitive Information Statement on Schedule 14C to its stockholders relating to the approval of the increase in authorized shares.
A copy of the Certificate of Amendment is filed
as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 3.1 |
|
Certificate of Amendment to the Amended and Restated Certificate of Incorporation |
| 104 |
|
Cover Page Interactive Data File (formatted in Inline XBRL). |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: December 9, 2025
| NATURE’S MIRACLE HOLDING INC. |
|
| |
|
| By: |
/s/ Tie (James) Li |
|
| Name: |
Tie (James) Li |
|
| Title: |
Chief Executive Officer |
|
2